Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Jan 25, 2022

SELL
$5.69 - $7.83 $830 - $1,143
-146 Closed
0 $0
Q3 2021

Oct 28, 2021

SELL
$7.88 - $14.0 $315 - $560
-40 Reduced 21.51%
146 $1,000
Q1 2021

Apr 30, 2021

BUY
$17.65 - $24.16 $3,282 - $4,493
186 New
186 $4,000

Others Institutions Holding HARP

About Harpoon Therapeutics, Inc.


  • Ticker HARP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 33,106,800
  • Description
  • Harpoon Therapeutics, Inc., a clinical-stage immunotherapy company, engages in the development of a novel class of T cell engagers that harness the power of the body's immune system to treat patients suffering from cancer and other diseases in the United States. The company develops tri-specific T cell activating construct (TriTAC) product candi...
More about HARP
Track This Portfolio

Track Signaturefd, LLC Portfolio

Follow Signaturefd, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Signaturefd, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Signaturefd, LLC with notifications on news.